204 related articles for article (PubMed ID: 21716879)
21. Elevated expression of HIF-lα in actively growing prostate tissues is associated with clinical features of benign prostatic hyperplasia.
Wu F; Ding S; Li X; Wang H; Liu S; Wu H; Bi D; Ding K; Lu J
Oncotarget; 2016 Mar; 7(11):12053-62. PubMed ID: 26919249
[TBL] [Abstract][Full Text] [Related]
22. Prostatic volume and ratio of free-to-total prostate specific antigen in patients with prostatic cancer or benign prostatic hyperplasia.
Haese A; Graefen M; Noldus J; Hammerer P; Huland E; Huland H
J Urol; 1997 Dec; 158(6):2188-92. PubMed ID: 9366341
[TBL] [Abstract][Full Text] [Related]
23. [Phenotyping of angiotensin-converting enzyme in the prostate in patients with prostate cancer and benign prostatic hyperplasia].
Mamedov VN; Danilov SM; Samokhodskaya LM; Okhobotov DA; Kamalov DM; Melnikov N; Karpov VK; Kadrev AV; Kamalov AA
Urologiia; 2020 Nov; (5):20-27. PubMed ID: 33185341
[TBL] [Abstract][Full Text] [Related]
24. Bipolar plasma enucleation of the prostate vs open prostatectomy in large benign prostatic hyperplasia cases - a medium term, prospective, randomized comparison.
Geavlete B; Stanescu F; Iacoboaie C; Geavlete P
BJU Int; 2013 May; 111(5):793-803. PubMed ID: 23469933
[TBL] [Abstract][Full Text] [Related]
25. Assessment of posterior urethra in benign prostatic hyperplasia and after its surgery.
Agrawal V; Khullar R; Jha AK
Urol Ann; 2020; 12(1):63-68. PubMed ID: 32015620
[TBL] [Abstract][Full Text] [Related]
26. [Immunohistochemical study of the prostatic tissues with monoclonal antibody against gamma-seminoprotein. Analyses of benign prostatic hyperplasia, metastatic foci from adenocarcinoma of the prostate and malignant neoplasms other than adenocarcinoma of the prostate].
Fujino A; Shimura S; Murayama M; Ao T; Yokoyama E; Mashimo S; Ishibashi A; Koshiba K; Kuwao S
Nihon Hinyokika Gakkai Zasshi; 1993 Mar; 84(3):527-34. PubMed ID: 7685842
[TBL] [Abstract][Full Text] [Related]
27. Oxidative damage in patients with benign prostatic hyperplasia and prostate cancer co-exposed to phthalates and to trace elements.
Chang WH; Lee CC; Yen YH; Chen HL
Environ Int; 2018 Dec; 121(Pt 2):1179-1184. PubMed ID: 30808488
[TBL] [Abstract][Full Text] [Related]
28. Sex steroid receptor expression and localization in benign prostatic hyperplasia varies with tissue compartment.
Nicholson TM; Sehgal PD; Drew SA; Huang W; Ricke WA
Differentiation; 2013; 85(4-5):140-9. PubMed ID: 23792768
[TBL] [Abstract][Full Text] [Related]
29. Comparison of 66 chemical element contents in normal and benign hyperplastic prostate.
Zaichick V; Zaichick S
Asian J Urol; 2019 Jul; 6(3):275-289. PubMed ID: 31297320
[TBL] [Abstract][Full Text] [Related]
30. Insulin-like growth factor-binding protein-2 in patients with prostate carcinoma and benign prostatic hyperplasia.
Ho PJ; Baxter RC
Clin Endocrinol (Oxf); 1997 Feb; 46(2):145-54. PubMed ID: 9135695
[TBL] [Abstract][Full Text] [Related]
31. Prevalence of histological prostatitis in men with benign prostatic hyperplasia or adenocarcinoma of the prostate presenting without urinary retention.
Edlin RS; Heyns CF; Van Vuuren SP; Zarrabi AD
S Afr J Surg; 2012 Nov; 50(4):127-30. PubMed ID: 23217554
[TBL] [Abstract][Full Text] [Related]
32. Zinc Deficiency in Men Over 50 and Its Implications in Prostate Disorders.
Sauer AK; Vela H; Vela G; Stark P; Barrera-Juarez E; Grabrucker AM
Front Oncol; 2020; 10():1293. PubMed ID: 32850402
[TBL] [Abstract][Full Text] [Related]
33. Serum levels of total and urine level of PCA3 in patients with benign prostatic hyperplasia and prostate cancer.
Askari M; Yazdani A; Yazdani M; Izadpanahi MH
Am J Clin Exp Urol; 2020; 8(1):43-47. PubMed ID: 32211453
[TBL] [Abstract][Full Text] [Related]
34. Comprehensive patient evaluation for benign prostatic hyperplasia.
Jepsen JV; Bruskewitz RC
Urology; 1998 Apr; 51(4A Suppl):13-8. PubMed ID: 9586591
[TBL] [Abstract][Full Text] [Related]
35. Transcriptomic analysis of benign prostatic hyperplasia identifies critical pathways in prostatic overgrowth and 5-alpha reductase inhibitor resistance.
Jin R; Forbes CM; Miller NL; Lafin J; Strand DW; Case T; Cates JM; Liu Q; Ramirez-Solano M; Mohler JL; Matusik RJ
Prostate; 2024 Apr; 84(5):441-459. PubMed ID: 38168866
[TBL] [Abstract][Full Text] [Related]
36. [Investigation of trace elements in hair of patients with prostate carcinoma, benign prostatic hypertrophy, and normal controls].
Ouyang SY; Li SL
Hunan Yi Ke Da Xue Xue Bao; 2000 Jun; 25(3):279-80. PubMed ID: 12212167
[TBL] [Abstract][Full Text] [Related]
37. Possible therapeutic role of zinc oxide nanoparticles versus vanillic acid in testosterone-induced benign prostatic hyperplasia in adult albino rat: A histological, immunohistochemical and biochemical study.
Abdel Fattah S; Ibrahim MEE; El-Din SS; Emam HS; Algaleel WAA
Life Sci; 2023 Dec; 334():122190. PubMed ID: 37866805
[TBL] [Abstract][Full Text] [Related]
38. [Who works in the prevention and early detection of benign prostatic hyperplasia and prostate cancer in Croatia?].
Kranjcević K; Marković BB
Acta Med Croatica; 2007 Feb; 61(1):45-8. PubMed ID: 17593640
[TBL] [Abstract][Full Text] [Related]
39. Androgen levels in the plasma and prostatic tissues of patients with benign hypertrophy and carcinoma of the prostate.
Habib FK; Lee IR; Stitch SR; Smith PH
J Endocrinol; 1976 Oct; 71(1):99-107. PubMed ID: 62008
[TBL] [Abstract][Full Text] [Related]
40. Prostate cancer antigen 3 gene expression in peripheral blood and urine sediments from prostate cancer and benign prostatic hyperplasia patients versus healthy individuals.
Moradi Sardareh H; Goodarzi MT; Yadegar-Azari R; Poorolajal J; Mousavi-Bahar SH; Saidijam M
Urol J; 2014 Nov; 11(6):1952-8. PubMed ID: 25433473
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
